ARTICLE
29 October 2020

BREAKING: Arthrex Headed To The Supreme Court

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
On Tuesday, the Supreme Court granted certiorari in the three appeals from the Federal Circuit's Arthrex decision, consolidating those three cases for briefing and argument.
United States Intellectual Property
To print this article, all you need is to be registered or login on Mondaq.com.

On Tuesday, the Supreme Court granted certiorari in the three appeals from the Federal Circuit's Arthrex decision, consolidating those three cases for briefing and argument.  The questions to be presented are as follows:

1. Whether, for purposes of the Appointments Clause, U.S. Const. Art. II, § 2, Cl. 2, administrative patent judges of the U.S. Patent and Trademark Office are principal officers who must be appointed by the President with the Senate's advice and consent, or "inferior Officers" whose appointment Congress has permissibly vested in a department head.

2. Whether, if administrative patent judges are principal officers, the court of appeals properly cured any Appointments Clause defect in the current statutory scheme prospectively by severing the application of 5 U.S.C. 7513(a) to those judges.

We will continue to report on developments.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More